Mbryonics Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mbryonics Ltd - overview
Established
2014
Location
Galway, -, Ireland
Primary Industry
Aerospace
About
Founded in 2014 and based in Galway, Ireland, Mbryonics Ltd operates as a provider of communication networks in the aerospace industry. In March 2024, Mbryonics Ltd raised EUR 15 million in venture funding from investor EIC Accelerator. The firm as of February 2025, is led by its co-founders, John Mackey (CEO), David Mackey (CTO), and Ruth Mackey (CSO and COO). The company, specializes in manufacturing, assembly, and testing to develop cutting-edge technologies for space communications.
MBRYONICS focuses on providing optical communications solutions for satellite systems, supporting missions across cislunar space and deep space, including quantum key distribution, data relay systems, and optical feeder links. The company's flagship product, StarCom, is an advanced optical communication system for inter-satellite and Earth links, known for its high-speed capabilities, reconfigurability, and ultra-lightweight design. It supports applications like satellite optical mesh networks and is compatible with third-party modems, offering reliable, high-throughput communications. The company generates revenue through the design, manufacture, and integration of optical communications systems and related services for both terrestrial and space applications.
The company plans to utilize the March 2024 funding to build a production plant.
Current Investors
State Street Digital
Primary Industry
Aerospace
Sub Industries
Aerospace
Website
www.mbryonics.com/
Verticals
Big Data, IoT (Internet of Things), Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Mbryonics Ltd - timeline of key events
Mbryonics Ltd - financials
| Fiscal Year Ended | Jul 10, 2019 | Jun 30, 2020 | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | 1,372,754 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | 53,954 | - | - | - |
| Operating Income (USD) | - | - | - | 19,232 | - | - | - |
| Operating Margin | - | - | - | 1.4% | - | - | - |
| % EBITDA Margin | - | - | - | 3.9% | - | - | - |
| NET Income (USD) | (92,572) | (90,857) | 153,870 | 206,017 | - | - | - |
| % Net Margin | - | - | - | 15.0% | - | - | - |
Mbryonics Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.